Prosecution Insights
Last updated: April 19, 2026

Examiner: DELLA, JAYMI E

Tech Center 3700 • Art Units: 3739 3794

This examiner grants 68% of resolved cases

Performance Statistics

68.5%
Allow Rate
-1.5% vs TC avg
867
Total Applications
+29.3%
Interview Lift
1537
Avg Prosecution Days
Based on 817 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
18.6%
§102 Novelty
37.3%
§103 Obviousness
25.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17131020 SURGICAL INSTRUMENT WITH SENSOR AND POWERED CONTROL Non-Final OA Cilag GmbH International
18118008 DEVICE, SYSTEM, AND METHOD FOR IMAGING AND TISSUE CHARACTERIZATION OF ABLATED TISSUE Non-Final OA PHILIPS IMAGE GUIDED THERAPY CORPORATION
17559579 FLEXIBLE RENAL NERVE ABLATION DEVICES AND RELATED METHODS OF USE AND MANUFACTURE Non-Final OA Boston Scientific Scimed, Inc.
17664580 ELECTROSURGICAL MEDICAL DEVICE WITH POWER MODULATION Final Rejection Covidien LP
18096228 OPTICAL TISSUE FEEDBACK DEVICE FOR AN ELECTROSURGICAL DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
18330778 ELECTROSURGICAL SYSTEM Non-Final OA Applied Medical Resources Corporation
18155493 Internal Cold Plasma System Non-Final OA Plasmology4, Inc.
18471677 METHOD AND SYSTEM OF CONTROL OF CONDUCTIVE FLUID DURING COAGULATION Non-Final OA Smith & Nephew Asia Pacific Pte. Limited
18544059 SIMPLIFIED BASKET CATHETERS HAVING MULTIPLE SPINES Final Rejection Biosense Webster (Israel) Ltd.
18458478 CATHETER, SYSTEM AND METHOD FOR COMBINED ABLATION MODALITIES Non-Final OA Biosense Webster (Israel) Ltd.
18352877 Multi-Purpose Sensing and Radiofrequency (RF) Ablation Spiral Electrode for Catheter Non-Final OA Biosense Webster (Israel) Ltd.
18348120 MEDICAL PROBE WITH WIRING DISPOSED BETWEEN TWO EXPANDABLE MEMBRANES Non-Final OA Biosense Webster (Israel) Ltd.
18152506 HEAT TRANSFER THROUGH AN ABLATION ELECTRODE Final Rejection Biosense Webster (Israel) Ltd.
17980015 PULSE GENERATOR FOR IRREVERSIBLE ELECTROPORATION Final Rejection Biosense Webster (Israel) Ltd.
17868945 TISSUE ABLATION USING HIGH-FREQUENCY UNIPOLAR IRE Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
17825073 TRANSSEPTAL TISSUE PUNCTURE APPARATUSES, SYSTEMS, AND METHODS Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
17079700 Pulse Generator for Irreversible Electroporation Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
18385698 BIPOLAR SPHINCTEROTOME Non-Final OA Cook Medical Technologies LLC
18385728 BIPOLAR SPHINCTEROTOME Non-Final OA Cook Medical Technologies LLC
18497767 BIPOLAR SPHINCTEROTOME Non-Final OA Cook Medical Technologies LLC
17719833 LOW-TEMPERATURE PLASMA CATHETER FOR LESS-INVASIVE, LOCALIZED TREATMENT OF ENDOCARDITIS AND ATHEROSCLEROSIS Non-Final OA The Penn State Research Foundation
18155478 SYSTEM AND METHOD FOR PERICARDIAL PUNCTURE Non-Final OA Boston Scientific Medical Device Limited
17038336 HELICAL PUSH WIRE ELECTRODE Non-Final OA Medtronic Ireland Manufacturing Unlimited Company
18219461 ELECTROSURGICAL BLADE WITH MINIMALLY EXPOSED EDGE, ALTERNATIVE TO COATED BLADE Non-Final OA Medtronic Advanced Energy LLC
18292626 ELECTRODE DEVICE FOR BLOCKING OR CONTROLLING NERVES IN BODY Non-Final OA DEEPQURE INC.
17190183 SYSTEMS FOR PERIVASCULAR NERVE DENERVATION Non-Final OA DeepQure Inc.
18542144 SKIN TREATMENT APPARATUS USING RF ENERGY HAVING OVERLAP TREATMENT PREVENTION FUNCTION, CONTROL METHOD THEREOF, AND SKIN TREATMENT METHOD USING SAME Non-Final OA LUTRONIC CORPORATION
18291334 ENERGY DELIVERY SYSTEMS WITH LESION INDEX Non-Final OA ENCHANNEL MEDICAL, LTD.
18376950 RF SHAVER AUXILIARY SUCTION Non-Final OA GYRUS MEDICAL LIMITED
18562514 Radial Pulse Field Ablation Catheter System Non-Final OA Mary Hitchcock Memorial Hospital, For Itself and On Behalf of Dartmouth-Hitchcock Clinic

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month